Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
10.65
+0.24 (2.31%)
At close: Nov 19, 2026, 4:00 PM EST
10.66
+0.01 (0.09%)
After-hours: Nov 19, 2026, 4:10 PM EST
Eloxx Pharmaceuticals Market Cap
Eloxx Pharmaceuticals has a market cap or net worth of $42.99 million as of November 19, 2026. It is the 30,489th most valuable company in the world and the 4,602nd biggest in the United States.
Market Cap
42.99M
Enterprise Value
-1.44M
1-Year Change
n/a
Global Rank
Country Rank
#4,602 United States
Category
ChartMarket Cap Chart
Since May 17, 2002, Eloxx Pharmaceuticals's market cap has increased from $36.80M to $42.99M, an increase of 16.82%. That is a compound annual growth rate of 0.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 42.99M | - |
| Dec 31, 2025 | - | - |
| Dec 31, 2024 | - | -100.00% |
| Dec 29, 2023 | 3.80M | -2.56% |
| Dec 30, 2022 | 3.90M | -93.60% |
| Dec 31, 2021 | 60.90M | -61.89% |
| Dec 31, 2020 | 159.80M | -45.72% |
| Dec 31, 2019 | 294.40M | -30.20% |
| Dec 31, 2018 | 421.80M | 1,947.57% |
| Dec 29, 2017 | 20.60M | 610.34% |
| Dec 30, 2016 | 2.90M | -64.63% |
| Dec 31, 2015 | 8.20M | -28.07% |
| Dec 31, 2014 | 11.40M | -40.00% |
| Dec 31, 2013 | 19.00M | 1.60% |
| Dec 31, 2012 | 18.70M | -10.95% |
| Dec 30, 2011 | 21.00M | 10.53% |
| Dec 31, 2010 | 19.00M | 126.19% |
| Dec 31, 2009 | 8.40M | -49.70% |
| Dec 31, 2008 | 16.70M | 32.54% |
| Dec 31, 2007 | 12.60M | -34.72% |
| Dec 29, 2006 | 19.30M | -12.27% |
| Dec 30, 2005 | 22.00M | -54.55% |
| Dec 31, 2004 | 48.40M | 22.22% |
| Dec 31, 2003 | 39.60M | 59.04% |
| Dec 31, 2002 | 24.90M | -32.34% |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 52.37M |
| Heron Therapeutics | 51.94M |
| Spero Therapeutics | 51.83M |
| Xilio Therapeutics | 50.95M |
| RenovoRx | 50.18M |
| Impact BioMedical | 48.82M |
| Clene | 48.67M |
| Verrica Pharmaceuticals | 48.44M |